Source: The Lancet Microbe. Unidades: FCFRP, ICB, FMVZ
Subjects: ANTIBIÓTICOS, GENÔMICA, RESISTÊNCIA MICROBIANA ÀS DROGAS, SEQUENCIAMENTO GENÉTICO, VARIAÇÃO GENÉTICA
ABNT
FURLAN, João Pedro Rueda et al. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance. The Lancet Microbe. London: The Lancet Publishing Group. Disponível em: https://doi.org/10.1016/S2666-5247(23)00249-5. Acesso em: 11 nov. 2024. , 2023APA
Furlan, J. P. R., Castillo, D. F., Stehling, E. G., Sellera, F. P., & Lincopan, N. (2023). The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance. The Lancet Microbe. London: The Lancet Publishing Group. doi:10.1016/S2666-5247(23)00249-5NLM
Furlan JPR, Castillo DF, Stehling EG, Sellera FP, Lincopan N. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance [Internet]. The Lancet Microbe. 2023 ; 4( 11): e857.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/S2666-5247(23)00249-5Vancouver
Furlan JPR, Castillo DF, Stehling EG, Sellera FP, Lincopan N. The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance [Internet]. The Lancet Microbe. 2023 ; 4( 11): e857.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/S2666-5247(23)00249-5